Leaflet NARATRIPTAN STADA HEMOFARM 2.5mg film-coated tablets

Product code:
W56650007
Quantity:
24
Indicated for:
migraine
Route of administration:
oral
Substance:
naratriptan (serotonin agonist antimigraine)
ATC
N02CC02 — Nervous system | Antimigraine preparations | Selective serotonin (5HT1) agonists

Precautions:

Breastfeeding warning

Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning

Pregnancy warning

Use during pregnancy only on medical advice.

Naratriptan is a medication used for the treatment of acute migraine, with or without aura. It belongs to the class of serotonin receptor agonists (triptans) and works by constricting dilated blood vessels in the brain, reducing pain and other migraine-associated symptoms.

The medication is taken orally, usually in tablet form, and is effective in providing rapid relief from migraine symptoms. It is intended for occasional use and should not be used for migraine prevention.

Side effects may include nausea, dizziness, fatigue, or a sensation of pressure in the chest. In rare cases, severe reactions such as high blood pressure or cardiac ischemia may occur.

Consult your doctor before use, especially if you have cardiovascular conditions or are taking other medications. Use Naratriptan as directed to avoid complications.

General data about NARATRIPTAN STADA HEMOFARM 2.5mg

Substance:
naratriptan
Date of latest medicines list:
01-07-2013
Product code:
W56650007
Concentration:
2.5mg
Pharmaceutical form:
film-coated tablets
Quantity:
24
Product type:
Generic medicine
Prescription status:
P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Marketing authorisation

Manufacturer:
CENTRAFARM SERVICES BV - OLANDA
Holder:
STADA HEMOFARM S.R.L. - ROMANIA
Number:
7929/2015/07
Shelf life:
4 years